Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose compared with a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Trial Identifier: EFC16335
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: May 2020
Primary Completion Date: November 2020
Study Completion Date: November 2020
Condition: Meningococcal Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
JAPAN Koganei-Shi, JAPAN
JAPAN Nagoya-Shi, JAPAN
JAPAN Shinjuku-Ku, JAPAN